5 ways to address pricing and access challenges across the E...
In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA Gene
GSK ends decades-long hiatus in oral antibiotics for UTIs
The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.
Character raises $93m for eye drugs, plus other financings
Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Returning for a 4th Year... GPCRs-Targeted Drug Discovery!
Transforming the Discovery of Novel GPCR-Targeted Therapies
LEAP HR: Life Sciences East
Save the Date for LEAP HR: Life Sciences East!
2nd ESG in Life Sciences Summit Europe
Mastering Life Science ESG Compliance & Strategic Impact in 2025
6th GxP Cloud Compliance Summit 2025
Advancing AI Advancing AI Validation, Risk Management, and Cloud Security to Ensure GxP Cloud Compliance
Innovation in Psychosis Therapeutics Summit
Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment